PolyMedica’s “advertising costs do not qualify for capitalization under the direct-response advertising exception.”

Today PolyMedica disclosed in its form 10-K for its fiscal year ended March 31, 2003:

Note U. Subsequent Events:

“For several months, we have been discussing the appropriateness of this practice [capitalizing direct-response advertising costs] with the SEC. On June 20, 2003, the SEC informed us that it believes that our advertising costs do not qualify for capitalization under the direct-response advertising exception in SOP 93-7.”

In a June 30, 2003 press release PolyMedica stated that if the company were to expense advertising costs as incurred “the company’s guidance for its fiscal 2004 first quarter ending June 30, 2003 would be $0.66-$0.72”, or $0.18 lower that its previous guidance.

Posted in PolyMedica Corporation

Manuel Asensio doesn’t bet often. But when he does, it’s wise to pay attention.

Paul Kaihla
eCompany Now
1 2 3 4 5 6 7 8 9
About Our Founder
Learn more about asensio.com's founder, Manuel P. Asensio, and the website's origins. Click here to be directed to Mr. Asensio’s professional biography.
Media Record
Click here to see selected articles that discuss asensio.com's work and its unique legacy. asensio.com also strives to maintain a complete record of articles dealing with the companies that are the subject of asensio.com research.
Investment Record
Click here to view a list of the companies that have been subjects of asensio.com reporting and click here to see the complete investment record.
Asensio and FINRA
Asensio & Company, Inc. and Manuel P. Asensio are the only dedicated short sellers ever to have been members of FINRA. This unique-minority membership created complications in the regulatory relationship. Being the first activist short investors and among the first FINRA member firms with a website added to the complexity. A statement by Mr. Asensio is available here. Information necessary to obtain a meaningful understanding of the dispute is available in complete form HERE.